These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8071825)

  • 21. Influence of diuretics and diazoxide on ions and vascular reactivity in normotensive and spontaneously hypertensive rats.
    Neuvonen PJ
    Ann Med Exp Biol Fenn; 1971; 49(3):109-19. PubMed ID: 5133789
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibitory effect of potassium on blood pressure in DOCA salt hypertension in rats.
    Suzuki H; Kondo K; Saruta T
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):525-32. PubMed ID: 7270008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro magnesium effects on aortic prostacyclin generation in DOCA-salt hypertensive rats.
    Laurant P; Moussard C; Alber D; Henry JC; Berthelot A
    Prostaglandins Leukot Essent Fatty Acids; 1992 Nov; 47(3):183-6. PubMed ID: 1475272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive and antioxidant effects of protocatechuic acid in deoxycorticosterone acetate-salt hypertensive rats.
    Safaeian L; Emami R; Hajhashemi V; Haghighatian Z
    Biomed Pharmacother; 2018 Apr; 100():147-155. PubMed ID: 29428662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular changes in DOCA hypertension. Influence of a low protein diet.
    Moreland RS; Webb RC; Bohr DF
    Hypertension; 1982; 4(5 Pt 2):III99-107. PubMed ID: 7106953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in vascular expression of endothelin and ET(A)/ET(B) receptors, but not in calcium handling mechanisms, in deoxycorticosterone acetate-salt hypertension.
    David FL; Montezano AC; Rebouças NA; Nigro D; Fortes ZB; Carvalho MH; Tostes RC
    Braz J Med Biol Res; 2002 Sep; 35(9):1061-8. PubMed ID: 12219177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress.
    Bhatia J; Tabassum F; Sharma AK; Bharti S; Golechha M; Joshi S; Sayeed Akhatar M; Srivastava AK; Arya DS
    Cardiovasc Toxicol; 2011 Sep; 11(3):272-9. PubMed ID: 21748534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor: a potent vasoconstrictor in experimental hypertension.
    Florian JA; Watts SW
    Am J Physiol; 1999 Mar; 276(3):H976-83. PubMed ID: 10070082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal function contributes to antihypertensive effect of vasopressin in DOCA-salt but not spontaneous hypertension.
    Wang H; McNeill JR
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1842-50. PubMed ID: 7977814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A comparative study of C19 steroid-induced hypertension and deoxycorticosterone acetate (DOCA)-salt hypertension].
    Minato M; Honda M; Hatano M
    Nihon Naibunpi Gakkai Zasshi; 1990 Jan; 66(1):29-41. PubMed ID: 2307256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma catecholamines, noradrenaline metabolism and vascular response in desoxycorticosterone acetate hypertension of rats.
    Rascher W; Schömig A; Dietz R; Weber J; Gross F
    Eur J Pharmacol; 1981 Nov; 75(4):255-63. PubMed ID: 7318911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pleiotropic effects of hydrogen peroxide in arteries and veins from normotensive and hypertensive rats.
    Thakali K; Davenport L; Fink GD; Watts SW
    Hypertension; 2006 Mar; 47(3):482-7. PubMed ID: 16432037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
    Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
    J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ouabain as an amplifier of mineralocorticoid-induced hypertension.
    Sekihara H; Yazaki Y; Kojima T
    Endocrinology; 1992 Dec; 131(6):3077-82. PubMed ID: 1446641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of estrogen on serum nitric oxide concentrations in normotensive and DOCA Salt hypertensive ovariectomized rats.
    Nematbakhsh M; Khazaei M
    Clin Chim Acta; 2004 Jun; 344(1-2):53-7. PubMed ID: 15149870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced vasopressin (V2-receptor)-induced sodium retention in mineralocorticoid hypertension.
    Jeffries WB; Wang Y; Pettinger WA
    Am J Physiol; 1988 May; 254(5 Pt 2):F739-46. PubMed ID: 2834967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats.
    Northcott CA; Poy MN; Najjar SM; Watts SW
    Circ Res; 2002 Aug; 91(4):360-9. PubMed ID: 12193470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered regulation of renal sodium transporters and natriuretic peptide system in DOCA-salt hypertensive rats.
    Bae EH; Kim IJ; Ma SK; Kim SW
    Regul Pept; 2009 Oct; 157(1-3):76-83. PubMed ID: 19422859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of DOCA on renal and gastrointestinal handling of sodium and potassium in pigs.
    Grigorian ME; Grekin RJ; Mitchell J; Dybus SP; Buiteweg JJ; Bohr DF
    Proc Soc Exp Biol Med; 1983 Nov; 174(2):265-9. PubMed ID: 6634720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.